Rxcurve
Medicare Part B payment limits Effective October 1 – December 31, 2026 Posted by CMS September 17, 2026
HCPCS Q5118 · per 10 MG

Inj., zirabev, 10 mg

Products billed under this code include Zirabev.

Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under Q5118

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Zirabev Pfizer Inc 00069-0315-01 10 $259.39
Zirabev Pfizer Inc 00069-0342-01 40 $1,037.56

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $25.939 +$0.05 10 MG Inj., zirabev, 10 mg v1, posted September 17, 2026
3Q26 $25.889 +$0.035 10 MG Inj., zirabev, 10 mg v1, posted September 15, 2026
2Q26 $25.854 +$0.055 10 MG Inj., zirabev, 10 mg v1, posted September 15, 2026
1Q26 $25.799 +$0.033 10 MG Inj., zirabev, 10 mg v1, posted September 15, 2026
4Q25 $25.766 +$1.836 10 MG Inj., zirabev, 10 mg v1, posted September 8, 2026
3Q25 $23.93 −$3.013 10 MG Inj., zirabev, 10 mg v1, posted March 10, 2026
2Q25 $26.943 +$3.943 10 MG Inj., zirabev, 10 mg v1, posted March 10, 2026
1Q25 $23.00 −$0.586 10 MG Inj., zirabev, 10 mg v1, posted December 19, 2025
4Q24 $23.586 +$2.616 10 MG Inj., zirabev, 10 mg v1, posted June 11, 2025
3Q24 $20.97 +$0.215 10 MG Inj., zirabev, 10 mg v1, posted June 11, 2025
2Q24 $20.755 −$0.756 10 MG Inj., zirabev, 10 mg v1, posted March 11, 2025
1Q24 $21.511 −$2.226 10 MG Inj., zirabev, 10 mg v1, posted December 19, 2024
4Q23 $23.737 −$2.431 10 MG Inj., zirabev, 10 mg v1, posted October 10, 2024
3Q23 $26.168 −$3.309 10 MG Inj., zirabev, 10 mg v1, posted June 5, 2024
2Q23 $29.477 −$3.202 10 MG Inj., zirabev, 10 mg v1, posted February 23, 2024
1Q23 $32.679 −$5.985 10 MG Inj., zirabev, 10 mg v1, posted December 6, 2023
4Q22 $38.664 −$3.198 10 MG Inj., zirabev, 10 mg v1, posted June 22, 2023
3Q22 $41.862 −$4.001 10 MG Inj., zirabev, 10 mg v1, posted June 9, 2023
2Q22 $45.863 −$4.726 10 MG Inj., zirabev, 10 mg v1, posted December 14, 2022
1Q22 $50.589 −$1.78 10 MG Inj., zirabev, 10 mg v1, posted June 8, 2022
4Q21 $52.369 −$2.816 10 MG Inj., zirabev, 10 mg v1, posted June 2, 2022
3Q21 $55.185 −$2.158 10 MG Inj., zirabev, 10 mg v1, posted June 2, 2022
2Q21 $57.343 −$2.128 10 MG Inj., zirabev, 10 mg v1, posted March 1, 2022
1Q21 $59.471 – 10 MG Inj., zirabev, 10 mg v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files